Please assess the completion status of the following clinical trial:

Trial Title: A Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension -AYAME Study-

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2/PHASE3
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Primary open angle glaucoma or ocular hypertension~Exclusion Criteria:~* Patients at risk of progression of visual field loss~* Patients with severe visual field defect~* Patients with any diseases that preclude participation in this study for safety reasons

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Placebo ophthalmic solution (Type: PLACEBO_COMPARATOR): Eyedrop
- DE-117 ophthalmic solution low (Type: EXPERIMENTAL): Eyedrop
- DE-117 ophthalmic solution high (Type: EXPERIMENTAL): Eyedrop
- Latanoprost ophthalmic solution 0.005% (Type: ACTIVE_COMPARATOR): Eyedrop

Based on this trial design, predict the completion outcome and termination type (if applicable).